CLOs on the Move

Conformis

www.conformis.com

 
Patients vary in more ways than gender, race, and size. At Conformis, we believe that optimizing implant fit and performance requires a patient-specific approach. Our mission is to provide best-in-class, patient-specific implants and instrumentation that offer unique advantages over traditional orthopedic implants. We start with a simple idea: make the implant fit the patient rather than forcing the patient to fit the implant. Our implants are individually sized and shaped to fit to each patient`s unique anatomy, providing precise anatomic fit and preserving healthy tissue. Our disposable, patient-specific cutting and placement guides also eliminate many of the tools required for ...
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.conformis.com
  • 600 Technology Park Drive
    Billerica, MA USA 01821
  • Phone: 781.345.9001

Executives

Name Title Contact Details
Emmanuel Nyakako
Senior Vice President of Quality and Regulatory Affairs Profile
Denise Pedulla
Chief Legal Officer and Corporate Secretary Profile
Brent Alldredge
Chief Legal Officer and Corporate Secretary Profile
Brent Alldredge
Chief Legal Officer and Corporate Secretary Profile
Patricia Davis
Chief Legal Officer and General Counsel Profile

Similar Companies

JK Associates

JK Associates is a Conshohocken, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ForeSee Health

ForeSee Health is a Chesterfield, MO-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Haven Health Ctr At Seacoast

Haven Health Ctr At Seacoast is a Hampton, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Vidacare Corporation

Vidacare Corporation is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in San Antonio, TX. To find more information about Vidacare Corporation, please visit www.vidacare.com

Juvenile Diabetes Research Foundation

JDRF is the leading global organization funding type 1 diabetes (T1D) research. Our strength lies in our exclusive focus and singular influence on the worldwide effort to end T1D.